5-alpha Reductase Inhibitors Humans Male Oxidoreductases Prospective Studies *Prostatic Hyperplasia/drug therapy *Prostatic Neoplasms/drug therapy 5?-reductase inhibitors Bph Prostate cancer cancer specific mortality meta-analysis

Aged Humans *Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Prospective Studies *Prostatic Hyperplasia Quality of Life Sulfonamides Tamsulosin Treatment Outcome benign prostatic hyperplasia lower urinary tract symptoms naftopidil tamsulosin

5-alpha Reductase Inhibitors/pharmacology Blood Loss Surgical/*prevention & control Blood Transfusion Dutasteride/*pharmacology Hemoglobins/analysis Humans Male Microcirculation Prospective Studies Prostate Prostatic Hyperplasia Randomized Controlled Trials as Topic Retrospective Studies *Transurethral Resection of Prostate Treatment Outcome Vascular Endothelial Growth Factor A/metabolism Benign prostatic hyperplasia Dutasteride Intraoperative blood loss Meta-analysis Transurethral resection of the prostate

Aged Blood Transfusion/statistics & numerical data Catheters Indwelling/statistics & numerical data Humans Laser Therapy Male Middle Aged Prospective Studies Prostatic Hyperplasia Randomized Controlled Trials as Topic Transurethral Resection of Prostate Treatment Outcome benign prostatic hyperplasia (BPH) prostate transurethral vaporesection transurethral resection of prostate (TURP)

Humans Cystectomy/adverse effects Prospective Studies Quality of Life *Robotics Treatment Outcome *Robotic Surgical Procedures/adverse effects Postoperative Complications/etiology *Urinary Bladder Neoplasms/pathology

Humans *Urinary Bladder/pathology Cystectomy/methods Prognosis Prospective Studies Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/pathology Biomarkers biomarker neutrophil-to-lymphocyte ratio prognostic factor radical cystectomy recurrence urothelial carcinoma

Cohort Studies *Dietary Fats/adverse effects Female Humans Male Prospective Studies Risk Factors Sugars *Urinary Bladder Neoplasms/epidemiology/etiology bladder cancer diet epidemiology fat oil risk factor

Cohort Studies Female Humans Male Prospective Studies Risk Factors Tea *Urinary Bladder Neoplasms/epidemiology/etiology Dose–response analysis Epidemiology Smoking Urinary bladder cancer

*Cell Cycle Proteins/genetics Humans Prospective Studies Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnosis/pathology Adxbladder Biomarker Bladder cancer Diagnostic accuracy Mcm5 Systematic review

Diet Fruit Humans Male Prospective Studies Risk Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology *Vegetables

Humans Magnetic Resonance Imaging *Multiparametric Magnetic Resonance Imaging Muscles Prospective Studies Urinary Bladder *Urinary Bladder Neoplasms/diagnostic imaging Bladder cancer Meta-analysis Muscle invasion Vesical imaging-reporting and data system

*Carcinoma Renal Cell/complications/epidemiology *Carcinoma Transitional Cell/complications/epidemiology Cross-Sectional Studies Hematuria/epidemiology/etiology Humans Incidence *Kidney Neoplasms/complications/epidemiology Male Prospective Studies Retrospective Studies Risk Factors *Urinary Bladder Neoplasms/complications/epidemiology Age distribution Cystoscopy Haematuria Kidney neoplasms Radiotherapy Sex Smoking Transitional cell carcinoma Urinary bladder neoplasms Urological neoplasms

Cohort Studies Diet Female Humans Male Prospective Studies Risk Factors Thiamine *Urinary Bladder Neoplasms/epidemiology/etiology/prevention & control Vitamin A Vitamin B 12 *Vitamin B Complex B group vitamins Bladder cancer Nutritional oncology Pooled cohort analysis

Humans *Carcinoma Transitional Cell/radiotherapy/surgery/drug therapy *Urinary Bladder Neoplasms Radiotherapy Adjuvant Retrospective Studies Prospective Studies Neoplasm Recurrence Local adjuvant radiotherapy external beam genitourinary locoregional control meta-analysis proximal ureter renal pelvis survival systematic review upper tract urothelial carcinoma

*Carcinoma Transitional Cell Case-Control Studies Epidemiologic Studies Female Folic Acid Humans Male Prospective Studies Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology/prevention & control

*Cystectomy/adverse effects Humans Postoperative Complications/epidemiology/etiology Prospective Studies Retrospective Studies *Robotic Surgical Procedures/adverse effects *Robotics Treatment Outcome *Urinary Bladder Neoplasms/surgery Bladder cancer Intracorporeal Meta-analysis Radical cystectomy Robot-assisted

*Cystectomy Humans Prospective Studies Systematic Reviews as Topic Treatment Outcome Urinary Bladder/pathology/surgery *Urinary Bladder Neoplasms/pathology/surgery models mortality nomograms radical cystectomy urinary bladder neoplasms

Humans Administration Intravesical Antibiotics Antineoplastic/administration & dosage Hematuria/drug therapy *Mitomycin/administration & dosage Prospective Studies Quality of Life Treatment Outcome *Urinary Bladder Neoplasms/drug therapy/pathology/surgery

Area Under Curve Female Humans Male Neoplasm Recurrence Local/diagnosis Prospective Studies Recurrence Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnosis Biomarker Bladder cancer Diagnostic accuracy Systematic review Xpert

Humans *Cystectomy/methods *Urinary Bladder Neoplasms/radiotherapy/surgery Urinary Bladder Radiotherapy Adjuvant/methods Prospective Studies Margins of Excision